Industry News

& Articles

ResMed Revenue Surges In Third Quarter of FY2020

Facebooktwitterlinkedin

San Diego-based medical device company, ResMed Inc has just delivered yet another set of outstanding results. In its results for the third quarter of FY2020, the firm witnessed a 16 per cent in revenue increase to $760.5 million, close to 20 per cent higher on a constant currency basis. Additionally, non-GAAP earnings per share jumped by 45 per cent, boosted by solid sales growth in the production of its sleeping masks.

The dual-listed company primarily implements cloud-connected medical software that transforms the lives of individuals with sleep apnoea and other chronic illnesses. The software that can be used beyond the boundaries of hospitals allows individuals to receive treatment in the comfort of their own homes or a setting of their own choice. More recently, ResMed is playing an increasingly critical role where it has been instructed by President Trump under the Defence Production Act to assist in the production of ventilators for COVID-19 patients.

As a result, the decision has witnessed the surge in revenues in the countries it operates in. Specifically, revenues in the US and Canada climbed 12 per cent due to sales in its product portfolio as well as increased demand for ventilators. Likewise, in Asia and Europe, these regions witnessed a 27 per cent growth in sales. Nevertheless, ResMed continues to do well in its software as a service segment where revenue jumped by 12 per cent as a result of continued growth in its service offerings such as MatrixCare and Brightree.

As of 2019, ResMed’s digital health products and breathing machines have successfully helped 105 million individuals across 140 countries. Yet, the firm is aiming to transform the lives of 250 million people by 2025. With more than 100 million lives within its digital health database, the magnitude of data it owns will certainly assist providers in gaining a good insight to bring the level of healthcare to the next level all while reducing costs.

Besides, the firm has played a huge emphasis on research and development (R&D). For the quarter ending 31 March 2020, ResMed has invested heavily within the research space. Specifically, R&D expenses were 15 per cent higher than that of the previous corresponding period. Recently, in a partnership with ATS Foundation to study how remote monitoring can assist in the management of patients with chronic obstructive pulmonary disease, ResMed has successfully received a third $100,000 research grant. With these funds, ResMed aims to be able to identify early in the process insights from daily recording and subsequently inform users of the appropriate time to seek more intensive treatment.

In terms of its product portfolio, the firm has also introduced its first tube-up full-face CPAP (continuous positive airway pressure) Mask. Also known as AirFit F30i, individuals who utilise full-face CPAP users will now find additional features on their face mask. Moving forward, the firm is confident that it will remain in an excellent position to weather through current macroeconomic conditions.

By Caroline Wong 

Click here for a 7 days access to our Lotus Blue Portal.

Comment on this company

Latest Stories

Macmahon Holdings Reaffirms FY20 Guidance

Coronavirus has had a massive impact worldwide and has shaken investor confidence in many…..

CIMIC Group Silent On Fresh Cash Flow Doubts

The international, multifaceted contractor CIMIC Group (ASX: CIM) has seen their Thiess.. …

Credit Corp Successfully Completes Share Purchase Plan

Local debt collection company, Credit Corp Limited (ASX: CCP), has today announced…..

More for you

Wisetech Reshuffles Payout Arrangements

Founder and CEO of WiseTech Global (ASX: WTC), Richard White oversaw renegotiations… …

Kogan.com Struggles To Appease Matt Blatt Customers

Turbulent macroeconomic developments across the world have created unique circumstances.. …

Seven Group Becomes Substantial Holder of Boral

Back in March when Australia was struggling to battle the coronavirus pandemic, Seven.. …

Woolworths Rewards Employees With $57m in Shares

Woolworths recognises the value of essential workers, with over 30,000 full-time employees each…..

UAC Energy Makes Attractive Bid for Infigen

UAC Energy Holdings has today, 03 June 2020, proposed a new addition to its business.. …

ACCC Intervenes in Qantas’ Acquisition

Qantas (ASX:QAN) has recently attracted scrutiny from the  Australian Competition and.. …

KOSEC Terms & Conditions

Kodari Securities Pty Ltd (CAR 399556) trading as KOSEC is regulated by the Australian Securities and Investment Commission (ASIC). KOSEC is a financial services company and any information provided by its platforms, portals, reports and documents is protected by copyright. Any unauthorised production of this information is prohibited.
KOSEC reserves the right to change or remove any information provided on our website, reports or any documents including these terms and conditions at any time without notice. The change or modification to the terms and conditions will be effective immediately upon posting an updated version on our website, necessary platforms and documents. It is recommended that you review the information provided on our website, including these terms and conditions frequently for any changes.

Disclaimer
KOSEC provides general advice only. The information provided is of a general nature only and does not take into account your individual objectives, financial situation or needs. It should not be used, relied upon, or treated as a substitute for specific professional advice. KOSEC recommends that you obtain your own independent professional advice before making any decision in relation to your particular requirements or circumstances. Please make sure you read our Financial Services Guide (FSG).

KOSEC does not guarantee any returns. Past performance of any product discussed is not indicative of future performance. (We urge that caution should be exercised in assessing past performance. All financial products are subject to market forces and unpredictable events that may adversely affect their future performance). Investing in the stock market can incur huge losses. Please also be aware that fees will incur on every transaction regardless of the performance of your investments or returns generated. Employees and or associates of KOSEC may hold one or more of the stocks, securities or investments reviewed by the company.

Your use of information from our website, reports, documents and from talking to our representatives/associates is at your risk. Under no circumstance should the investment be based solely on KOSEC information and general advice. You should seek professional financial planning advice.
KOSEC aims to maintain the accuracy of the data and information provided on this website, by using information prepared from a wide variety of sources, which KOSEC to the best of its knowledge and belief, considers accurate and does not make any representations or warranties of any kind, expressed or implied, about the completeness, accuracy, reliability, suitability or availability of the information provided.

We may at times refer to third parties, which the details of these third parties have been provided solely for you to obtain further information about other relevant products and entities in the market. KOSEC has no control over the information third parties have, or the products or services offered, and therefore make no representations regarding the accuracy or suitability of such information, products or services. You are advised to make your own enquiries in relation to third parties. Our inclusion of any third party content is not an endorsement of that content or the third party.

Fees
As a client you will be charged a yearly service fee and a set brokerage fee per transaction. Your service fee will automatically renew at the end of your agreed 12 month period at the same rate advertised at the time. Your credit card or bank account will be charged for a further year following which will again auto renew until you cancel your yearly service fee. You can cancel the auto renewal at any time in advance of the renewal date by contacting us. KOSEC is aware of the need to ensure the security of your credit card details and our payment systems are compliant with the Payment Card Industry (PCI) Data Security Standard.

Privacy
You consent to receiving email correspondence from KOSEC, as well as companies KOSEC has an association with. These emails will be sent by KOSEC and third party companies. You can opt out of receiving any category of emails at any time by contacting us. We may from time to time inform you of special offers, or even ask your opinion of the services we provide, but your involvement is optional. Should you request us to do so, we will archive your details.

Indemnity and Liability
You indemnify KOSEC from all claims or threatened claims, suits, demands, damages, costs as well as including legal costs incurred in dealing with any threatened claim, expenses made by any person or corporation against KOSEC and any other amounts which is caused by KOSEC providing information, execution and General Advice.

You hold KOSEC harmless and release it from any liability in respect of any loss, harm or damage arising from a decision made by you on the basis of information obtained through the use of our portal, reports, documents or any General Advice given and any transaction taken place.

You hold KOSEC harmless and release it from any liability in respect of any loss, harm or damage arising from delays in executing orders for the client and acknowledges KOSEC makes no guarantees about the time taken to execute an order on behalf of the client. You acknowledge that KOSEC relies on third parties in providing technology and release KOSEC from any harm, loss or damage you may suffer as a result of the failure of such information technology.

Cookies and Links
KOSEC website, and its portal uses cookies, which lets us identify your browser while you are using the site or our portal. Cookies do not identify you personally. They simply allow us to track your usage patterns. If you prefer not to receive cookies, you can configure your browser to reject them or to notify you when they are being used. The functionality of the KOSEC website may be impacted if you restrict the use of cookies.

Fill up the form below and we will get back to you as soon as possible.

CLAIM YOUR FREE E-BOOK &
7 DAY ACCESS TO LOTUS BLUE

STOCK MARKET SUCCESS

KOSEC’s CEO, Michael Kodari’s new book, “Stock Market Success” valued at $39.95, available at Dymocks book stores with all the proceeds going to Dymocks Children’s Charities.

CLAIM YOUR FREE E-BOOK WHEN YOU LOGIN TO LOTUS BLUE INVESTMENT PORTAL

Latest TV Commercial